Toll-Like Receptor-4 Disruption Suppresses Adipose Tissue Remodeling and Increases Survival in Cancer Cachexia Syndrome
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toll-Like Receptor-4 Disruption Suppresses Adipose Tissue Remodeling and Increases Survival in Cancer Cachexia Syndrome
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-12-17
DOI
10.1038/s41598-018-36626-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atorvastatin Inhibits Inflammatory Response, Attenuates Lipid Deposition, and Improves the Stability of Vulnerable Atherosclerotic Plaques by Modulating Autophagy
- (2018) Shi Peng et al. Frontiers in Pharmacology
- Cancer-associated cachexia
- (2018) Vickie E. Baracos et al. Nature Reviews Disease Primers
- Effect of statins on toll-like receptors: a new insight to pleiotropic effects
- (2018) Afsane Bahrami et al. PHARMACOLOGICAL RESEARCH
- Early suppression of adipocyte lipid turnover induces immunometabolic modulation in cancer cachexia syndrome
- (2017) Felipe Santos Henriques et al. FASEB JOURNAL
- Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways
- (2017) Guohua Zhang et al. Scientific Reports
- Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
- (2017) Wei Gao et al. Frontiers in Physiology
- PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer
- (2016) Serkan Kir et al. Cell Metabolism
- Treat wasting illness on multiple fronts
- (2016) Kenneth Fearon NATURE
- An AMP-activated protein kinase–stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice
- (2016) Maria Rohm et al. NATURE MEDICINE
- Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia
- (2016) Tomoya Fukawa et al. NATURE MEDICINE
- Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia
- (2016) Maria Tsoli et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Nutrition in cachexia: from bench to bedside
- (2016) Masaaki Konishi et al. Journal of Cachexia Sarcopenia and Muscle
- Understanding cachexia as a cancer metabolism syndrome
- (2016) P E Porporato Oncogenesis
- Cachexia-associated adipose tissue morphological rearrangement in gastrointestinal cancer patients
- (2015) Miguel L. Batista et al. Journal of Cachexia Sarcopenia and Muscle
- Cancer cachexia, mechanism and treatment
- (2015) Tomoyoshi Aoyagi et al. World Journal of Gastrointestinal Oncology
- Pioglitazone Treatment Increases Survival and Prevents Body Weight Loss in Tumor–Bearing Animals: Possible Anti-Cachectic Effect
- (2015) Mércia Beluzi et al. PLoS One
- A Switch from White to Brown Fat Increases Energy Expenditure in Cancer-Associated Cachexia
- (2014) Michele Petruzzelli et al. Cell Metabolism
- Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia
- (2014) Serkan Kir et al. NATURE
- Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance
- (2014) Peter Arner et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Immune Cell Toll-like Receptor 4 Mediates the Development of Obesity- and Endotoxemia-Associated Adipose Tissue Fibrosis
- (2014) Isabelle K. Vila et al. Cell Reports
- Inflammation Based Regulation of Cancer Cachexia
- (2014) Jill K. Onesti et al. Biomed Research International
- Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells
- (2012) A. Iwata et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients
- (2012) M.L. Batista et al. CYTOKINE
- Understanding the mechanisms and treatment options in cancer cachexia
- (2012) Kenneth Fearon et al. Nature Reviews Clinical Oncology
- Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem
- (2012) Maria Tsoli et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Regulation of Fasting Fuel Metabolism by Toll-Like Receptor 4
- (2010) S. Pang et al. DIABETES
- Atorvastatin affects TLR4 clustering via lipid raft modulation
- (2010) Praveen Chansrichavala et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Toll-Like Receptor Signaling and Liver Fibrosis
- (2010) Tomonori Aoyama et al. Gastroenterology Research and Practice
- Toll-Like Receptor 4: A Novel Signaling Pathway During Renal Fibrogenesis
- (2009) Matthew T. Campbell et al. JOURNAL OF SURGICAL RESEARCH
- TLRs and innate immunity
- (2008) B. A. Beutler BLOOD
- LPS/TLR4 signal transduction pathway
- (2008) Yong-Chen Lu et al. CYTOKINE
- Discovery and Development of Toll-Like Receptor 4 (TLR4) Antagonists: A New Paradigm for Treating Sepsis and Other Diseases
- (2008) Carlos G. Leon et al. PHARMACEUTICAL RESEARCH
- Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression
- (2008) Conrad P. Hodgkinson et al. Pharmacogenetics and Genomics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started